Allogeneic stem cell transplant in non-Hodgkin lymphomas: Still an indication?

被引：8
作者：
Dreger, Peter [1 ]
机构：
[1] Heidelberg Univ, Dept Med 5, Neuenheimer Feld 410, D-69120 Heidelberg, Germany
来源：
HEMATOLOGICAL ONCOLOGY | 2021年 / 39卷
关键词：
allogeneic transplantation; CAR-T cells; lymphoma; NHL;
D O I：
10.1002/hon.2845
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Allogeneic hematopoietic cell transplantation (alloHCT) used to play a defined role in the treatment of non-Hodgkin lymphoma (NHL). With the advent of modern targeted molecular therapies and immunotherapies, treatment standards at least for B-cell lymphoma have undergone significant changes, thereby questioning the traditional role of alloHCT in these diseases. This paper attempts to describe the current place and the perspectives of alloHCT in the rapidly evolving treatment landscape of NHL.
引用
收藏
页码：100 / 103
页数：4
相关论文
共 15 条
  • [1] The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma
    Chihara, Dai
    Fanale, Michelle A.
    Miranda, Roberto N.
    Noorani, Mansoor
    Westin, Jason R.
    Nastoupil, Loretta J.
    Hagemeister, Fredrick B.
    Fayad, Luis E.
    Romaguera, Jorge E.
    Samaniego, Felipe
    Turturro, Francesco
    Lee, Hun J.
    Neelapu, Sattva S.
    Rodriguez, M. Alma
    Wang, Michael
    Fowler, Nathan H.
    Davis, Richard E.
    Medeiros, L. Jeffrey
    Hosing, Chitra
    Nieto, Yago L.
    Oki, Yasuhiro
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (05) : 750 - 758
  • [2] Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
    d'Amore, F.
    Gaulard, P.
    Truemper, L.
    Corradini, P.
    Kim, W. -S.
    Specht, L.
    Pedersen, M. Bjerregaard
    Ladetto, M.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : V108 - V115
  • [3] CAR T cells or allogeneic transplantation as standard of care for advanced large B-cell lymphoma: an intent-to-treat comparison
    Dreger, Peter
    Dietrich, Sascha
    Schubert, Maria-Luisa
    Selberg, Lorenz
    Bondong, Andrea
    Wegner, Mandy
    Stadtherr, Peter
    Kimmich, Christoph
    Kosely, Florentina
    Schmitt, Anita
    Pavel, Petra
    Liebers, Nora
    Luft, Thomas
    Hegenbart, Ute
    Radujkovic, Aleksandar
    Ho, Anthony Dick
    Mueller-Tidow, Carsten
    Schmitt, Michael
    [J]. BLOOD ADVANCES, 2020, 4 (24) : 6157 - 6168
  • [4] Cellular Immunotherapy for Refractory Diffuse Large B Cell Lymphoma in the Chimeric Antigen Receptor-Engineered T Cell Era: Still a Role for Allogeneic Transplantation?
    Dreger, Peter
    Fenske, Timothy S.
    Montoto, Silvia
    Pasquini, Marcelo C.
    Sureda, Anna
    Hamadani, Mehdi
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (04) : E77 - E85
  • [5] SUCCESSFUL ALLOGENIC BONE MARROW TRANSPLANTATION IN MAN - CHIMERISM INDUCED SPECIFIC TOLERANCE AND POSSIBLE ANTI-LEUKEMIC EFFECTS
    MATHE, G
    AMIEL, JL
    SCHWARZE.L
    CATTAN, A
    SCHNEIDE.M
    DEVRIES, MJ
    TUBIANA, M
    LALANNE, C
    BINET, JL
    PAPIERNI.M
    SEMAN, G
    MATSUKUR.M
    MERY, AM
    SCHWARZM.V
    FLAISLER, A
    [J]. BLOOD-THE JOURNAL OF HEMATOLOGY, 1965, 25 (02): : 179 - &
  • [6] Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma
    Pasquini, Marcelo C.
    Hu, Zhen-Huan
    Curran, Kevin
    Laetsch, Theodore
    Locke, Frederick
    Rouce, Rayne
    Pulsipher, Michael A.
    Phillips, Christine L.
    Keating, Amy
    Frigault, Matthew J.
    Salzberg, Dana
    Jaglowski, Samantha
    Sasine, Joshua P.
    Rosenthal, Joseph
    Ghosh, Monalisa
    Landsburg, Daniel
    Margossian, Steven
    Martin, Paul L.
    Kamdar, Manali K.
    Hematti, Peiman
    Nikiforow, Sarah
    Turtle, Cameron
    Perales, Miguel-Angel
    Steinert, Patricia
    Horowitz, Mary M.
    Moskop, Amy
    Pacaud, Lida
    Yi, Lan
    Chawla, Raghav
    Bleickardt, Eric
    Grupp, Stephan
    [J]. BLOOD ADVANCES, 2020, 4 (21) : 5414 - 5424
  • [7] Robinson S., 2020, HEMATOL ONCOL, V37, P316
  • [8] Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party
    Robinson, Stephen P.
    Boumendil, Ariane
    Finel, Herve
    Peggs, Karl S.
    Chevallier, Patrice
    Sierra, Jorge
    Finke, Juergen
    Poire, Xavier
    Maillard, Natacha
    Milpied, Noel
    Yakoub-Agha, Ibrahim
    Koh, Mickey
    Kroeger, Nicolaus
    Nagler, Arnon
    Koc, Yener
    Dietrich, Sascha
    Montoto, Silvia
    Dreger, Peter
    [J]. BONE MARROW TRANSPLANTATION, 2018, 53 (05) : 617 - 624
  • [9] A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL
    Schmitz, Norbert
    Truemper, Lorenz
    Bouabdallah, Krimo
    Ziepert, Marita
    Leclerc, Mathieu
    Cartron, Guillaume
    Jaccard, Arnaud
    Reimer, Peter
    Wagner, Eva
    Wilhelm, Martin
    Sanhes, Laurence
    Lamy, Thierry
    de Leval, Laurence
    Rosenwald, Andreas
    Roussel, Muriel
    Kroschinsky, Frank
    Lindemann, Walter
    Dreger, Peter
    Viardot, Andreas
    Milpied, Noeel
    Gisselbrecht, Christian
    Wulf, Gerald
    Gyan, Emmanuel
    Gaulard, Philippe
    Bay, Jacques Olivier
    Glass, Bertram
    Poeschel, Viola
    Damaj, Gandhi
    Sibon, David
    Delmer, Alain
    Bilger, Karin
    Banos, Anne
    Haenel, Mathias
    Dreyling, Martin
    Metzner, Bernd
    Keller, Ulrich
    Braulke, Friederike
    Friedrichs, Birte
    Nickelsen, Maike
    Altmann, Bettina
    Tournilhac, Olivier
    [J]. BLOOD, 2021, 137 (19) : 2646 - 2656
  • [10] Allogeneic hematopoietic stem cell transplantation for T-cell lymphomas
    Schmitz, Norbert
    Lenz, Georg
    Stelljes, Matthias
    [J]. BLOOD, 2018, 132 (03) : 245 - 253
12